Financial Data and Key Metrics Changes - In Q1 2025, the company reported double-digit increases in organic net revenue, operating income, and adjusted diluted EPS in both constant currency and dollar terms [6][11][12] - Organic net revenue growth was plus 10.2%, reaching $9.3 billion, with volume growth of plus 3.9% [12][14] - Adjusted diluted EPS grew by plus 17.3% in constant currency and by plus 12.7% in dollar terms to $1.69, despite a $0.07 unfavorable currency variance [14][59] Business Line Data and Key Metrics Changes - The smoke-free business saw shipment volumes increase by plus 14.4% year-on-year, with organic net revenue growth of plus 20% and organic gross profit growth of plus 33% [6][16] - IQOS delivered close to plus 10% HTU-adjusted IMS growth, with strong performance in Japan and Europe [7][11] - ZYN shipments increased by plus 53% to reach 202 million cans, exceeding initial expectations [8][43] Market Data and Key Metrics Changes - The international nicotine pouch can volumes grew by plus 53%, or plus 182% excluding the Nordics, indicating strong global demand [9][50] - In Europe, total shipments of IQOS advanced by plus 17.5% in Q1, with significant growth in markets like Spain, Germany, and Bulgaria [30][32] - The cigarette industry declined by 1.3% in Q1, with growth in markets where smoke-free products are not present, such as Turkey and India [54] Company Strategy and Development Direction - The company continues to deploy a multi-category strategy across markets, with smoke-free products now accounting for 44% of total gross profit [6][7] - The focus remains on expanding the smoke-free portfolio, with significant investments in brand building and product innovation [29][30] - The company aims to achieve double-digit growth for the rest of the year and has raised its shipment forecast for ZYN to 800 million to 840 million cans per year [12][58] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving another year of super growth despite uncertainties in the global economic outlook [11][59] - The company anticipates continued strong momentum from its smoke-free business and expects to mitigate potential supply chain challenges [57][65] - Management highlighted the importance of maintaining a progressive dividend policy while focusing on sustainable growth [65][66] Other Important Information - The company delivered over $180 million in gross cost savings in Q1, placing it on track to achieve a $2 billion target over 2024-2026 [27] - The company is committed to investing in U.S. manufacturing, with significant job creation expected as a result [49] Q&A Session Summary Question: ZYN out-of-stock issues and inventory rebuilding timeline - Management acknowledged ongoing out-of-stock issues and indicated that replenishment would occur gradually, with normalization expected by Q3 2025 [68][73] Question: Drivers of continued margin expansion - Management highlighted that smoke-free products are driving margin expansion, with a significant organic gross margin increase in Q1 [75][78] Question: Guidance outlook for the second half of the year - Management indicated that traditional differences between H1 and H2 could affect growth rates, but overall strong momentum is expected [85][89] Question: Unconstrained growth for ZYN - Management noted that while they cannot provide precise estimates for unconstrained demand, they expect consumer offtake to accelerate as supply constraints are lifted [100][102] Question: Net interest cost guidance for the year - Management did not provide specific guidance for net interest costs but indicated a positive start to the year [116][119]

Core Insights - Philip Morris International Inc. (PM) reported strong first-quarter 2025 results, with both revenue and earnings exceeding expectations, leading to a nearly 3.5% increase in share price during pre-market trading [1][2] - The company raised its adjusted earnings per share (EPS) guidance for 2025, reflecting positive momentum across various regions and product categories [1][11] Financial Performance - Adjusted EPS for the first quarter was $1.69, a 12.7% increase year over year, surpassing the Zacks Consensus Estimate of $1.61 [2] - Net revenues reached $9,301 million, up 5.8% on a reported basis and 10.2% on an organic basis, exceeding the Zacks Consensus Estimate of $8,946.3 million [2] - The adjusted operating income rose 12.8% to $3,790 million, driven by improved pricing and positive volume/mix, despite increased costs in marketing and administration [5] Product Performance - Revenues from smoke-free products increased by 15% (20.4% organically), accounting for 42% of total revenues, with strong performance from IQOS and ZYN [4] - Shipment volumes for total products increased by 3.9% to 187.8 billion units in the first quarter [4] Regional Performance - European net revenues grew 3% (8.6% organically) to $3,560 million, supported by positive pricing and volume [7] - In the Americas, revenues surged 27.2% (32% organically) to $1,267 million, driven by favorable volume and pricing [8] Future Outlook - For 2025, adjusted EPS is projected to be in the range of $7.36-$7.49, indicating a growth of 12-14% [11] - The company expects net revenues to increase by 6-8% on an organic basis and operating income to rise by 10.5-12.5% [13] - Operating cash flow is anticipated to exceed $11 billion in 2025, with capital expenditures around $1.5 billion [13]

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive's content includes insights across various sectors such as biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - Proactive is committed to adopting technology to enhance workflows and improve content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]

Group 1 - Philip Morris reported quarterly earnings of $1.69 per share, exceeding the Zacks Consensus Estimate of $1.61 per share, and up from $1.50 per share a year ago, representing an earnings surprise of 4.97% [1] - The company achieved revenues of $9.3 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.97%, and an increase from $8.79 billion year-over-year [2] - Philip Morris has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Group 2 - The stock has increased approximately 36.4% since the beginning of the year, contrasting with a -10.1% decline in the S&P 500 [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The trend for estimate revisions for Philip Morris is currently favorable, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Group 3 - The current consensus EPS estimate for the upcoming quarter is $1.81 on revenues of $10.04 billion, and for the current fiscal year, it is $7.23 on revenues of $40.6 billion [7] - The Tobacco industry is ranked in the top 21% of Zacks industries, suggesting a positive outlook for stocks within this sector [8]

Championing a Smoke-Free World 2025 First-Quarter Results April 23, 2025 Introduction • A glossary of terms as well as adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures for non-GAAP financial measures cited in this presentation are available in Exhibit 99.2 to the company's Form 8-K dated April 23, 2025 and on our Investor Relations website 2 Forward-Looking and Cautionary Statements Excellent Q1 Marks Strong Start to 2025 (a) At prevailing exchange rates ...

Valuation and Performance - Altria Group, Inc. (MO) trades at a forward 12-month price-to-earnings (P/E) ratio of 11.01, which is a 24% discount compared to the Zacks Tobacco industry average of 14.49 [1] - Over the past 12 months, Altria stock has returned 37.1%, significantly underperforming the industry average of 54.3% [3] - The stock's performance is notably weaker compared to competitors like Philip Morris International Inc. (65.8% return) and Turning Point Brands, Inc. (106.1% return) [3] Market Challenges - Altria faces a decline in cigarette consumption, with smoking rates at historic lows, leading to a shrinking core customer base [6] - The company’s traditional cigarette market share is under pressure due to falling shipment volumes, which declined by 8.8% in Q4 2024 [9] - Younger demographics are increasingly turning away from traditional cigarettes, favoring smoke-free alternatives, compounded by the rise of illicit e-vapor products [7][8] Regulatory and Competitive Landscape - The U.S. Food and Drug Administration (FDA) has tightened marketing restrictions, adding to Altria's challenges [8] - The e-vapor category grew by around 30% in 2024, with illegal products accounting for over 60% of total category sales, undermining Altria's market expansion efforts [11][12] - Altria's Smoke-Free Strategy is hindered by the rapid rise of illicit flavored disposable e-vapor products, complicating regulatory enforcement [10][12] Financial Outlook - The Zacks Consensus Estimate for Altria's earnings per share has been revised downward over the past 30 days, indicating a bearish outlook among analysts [13] - Current estimates for earnings per share are 1.17 for the current quarter and 5.28 for the current year, reflecting a downward trend from previous estimates [13] Conclusion - The combination of declining cigarette volumes, regulatory hurdles, and the growing popularity of illicit e-vapor products presents a challenging outlook for Altria [14] - Until there is evidence of a successful transition to a more sustainable product mix, the stock's discount is likely to persist, leading to a cautious stance on new investments [14]

智通财经4月23日电，美国烟草公司Philip Morris第一季度调整后每股收益1.69美元，预估1.61美元。 ...

Philip Morris International Inc. PM will release its first-quarter financial results before the opening bell on Wednesday, April 23. Analysts expect the company to report quarterly earnings at $1.61 per share, up from $1.50 per share in the year-ago period. According to data from Benzinga Pro, Philip Morris International projects quarterly revenue of $9.14 billion, compared to $8.79 billion a year earlier. On April 16, Citigroup analyst Simon Hales maintained Philip Morris Intl with a Buy rating and raised ...

Group 1 - The article emphasizes the importance of dividend investing in quality blue-chip stocks, BDCs, and REITs for building a sustainable retirement income [1] - The author aims to assist lower and middle-class workers in creating investment portfolios focused on high-quality, dividend-paying companies [1] - The perspective provided is intended to help investors achieve financial independence through strategic investment choices [1] Group 2 - The author has a beneficial long position in the shares of MO, indicating a personal investment interest in the company [2] - The article expresses the author's own opinions and is not influenced by compensation from any company mentioned [2] - There is no business relationship between the author and any company whose stock is discussed, ensuring an unbiased viewpoint [2]

Group 1 - Altria's stock is currently viewed with caution due to geopolitical market uncertainty, despite its attractive 7.2% dividend yield [1] - The company's primary product, cigarettes, is addictive, leading to consistent consumer demand even during economic downturns, which may appeal to income-focused investors in 2025 [2][3] - Altria has demonstrated strong pricing power, consistently increasing product prices to support dividend growth, which has been raised annually since 2009 [4] Group 2 - The dividend payout ratio was approximately 60% in 2024, indicating that while it is somewhat high, it is manageable for a consumer staples company, suggesting near-term dividend safety [5] - Despite the current resilience, Altria faces long-term challenges as cigarette volumes have been declining, with a significant drop of 10.2% in 2024 [6] - Investors should monitor Altria closely, as it is not a company that can be held indefinitely without scrutiny, even if it maintains dividend payments in the short term [7] Group 3 - The ongoing decline in cigarette volumes raises concerns about the sustainability of Altria's business model, as price increases may eventually exacerbate the issue [8] - Altria is actively seeking to diversify its product offerings to counteract cigarette volume declines, but past efforts in vaping and marijuana have faced challenges, including a patent lawsuit with Juul [10] - For investors seeking high-yield opportunities, there are alternative companies with stronger business fundamentals compared to Altria, despite its current yield [11] Group 4 - Altria may be a suitable choice for investors looking for high yield and resilience in the current geopolitical climate, but long-term trends are concerning [12]